Viking Therapeutics (VKTX) Misses Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CRWD
5. CHKP
6. ON
7. DOX
8. HNGE
9. INSP
10. SPY

Go back to Viking Therapeutics (VKTX) Misses Q4 EPS by 4c

Citi Starts Viking Therapeutic (VKTX) at Neutral

February 7, 2025 6:52 AM EST

Citi analyst David Lebowitz initiates coverage on Viking Therapeutic (NASDAQ: VKTX) with a Neutral rating and a price target of $38.00.

The analyst comments "The relatively recent emergence of GLP-1s for the treatment of obesity has rapidly established a megamarket opportunity... More

Viking Therapeutic (VKTX) PT Lowered to $95 at Truist Securities

February 6, 2025 12:07 PM EST

Truist Securities analyst Joon Lee lowered the price target on Viking Therapeutic (NASDAQ: VKTX) to $95.00 (from $120.00) while maintaining a Buy rating.

The analyst comments "4Q24 update narrowed timeline for the start of 2x Ph3 studies of SQVK2735 in obesity. Toplines from Ph3... More